FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162912386> ?p ?o ?g. }

• W2162912386 endingPage "861" @default.
• W2162912386 startingPage "855" @default.
• W2162912386 abstract "Theophylline absorption from three sustained-release formulations was evaluated in 18 healthy men. First, a 600-mg oral dose of aminophylline, a rapidly absorbed formulation, was studied to confirm that theophylline clearance was in the expected range (mean ± SD, 0.710 ± 0.096 mL/min/kg), t1/2 = 6.9 ± 1.1 hr. Then each of the three sustained-release formulations was given at one hour before breakfast for eight days to achieve steady state. Multiple blood samples were drawn on days 7 and 8 over two complete dosing intervals. After a six-day drug-free period each subject was crossed over to the next product. At steady state, mean fluctuations of serum theophylline levels were more than 200% with Theo-Dur (Key Pharmaceuticals, Miami, FL), more than 150% with Uniphyl (Purdue-Frederick, Norwalk, CT), and about 75% with Theo-24 (Searle Laboratories, Chicago, IL). Theophylline Cmax levels averaged 16.5 μg/mL after 900 mg Theo-Dur, with 8% exceeding 20 μg/mL. Despite these high peak levels, nearly half of the Cmin levels were below 5 pg/mL. Uniphyl administration resulted in three-fourths of trough levels to be at 5 μg/mL or lower. Peak levels from 800-mg daily doses of Uniphyl were also low, with 42% never reaching 10 pg/mL. With Theo-24 only 17% of trough levels were below 5 μg/mL, as compared to 47% with Theo-Dur and 72% with Uniphyl. The three products differed in the areas under the serum concentration-time curves (AUC), which reflect bioavailability. Theo-Dur AUC was nearly equivalent to that of rapidly absorbed aminophylline (when adjusted for dosage). AUC from Theo-24 was 80% relative to Theo-Dur, and Uniphyl was 67%, when adjusted for dose. These data show the limitations in once-daily administration of sustained-release theophylline, even in normal and slow metabolizers. Serum levels fluctuated widely with Theo-Dur and Uniphyl, whereas the latter had incomplete bioavailability. Of the three products approved in the United States for once-daily dosing, only Theo-24 consistently yielded serum theophylline levels within the desired range while providing acceptable bioavailability." @default.
• W2162912386 created "2016-06-24" @default.
• W2162912386 creator A5023234261 @default.
• W2162912386 creator A5048130211 @default.
• W2162912386 creator A5066954652 @default.
• W2162912386 date "1987-11-01" @default.
• W2162912386 modified "2023-09-26" @default.
• W2162912386 title "Theophylline Absorption from Sustained-Release Products: Comparative Steady-State Bioavailability of Once-Daily Theo-Dur, Theo-24, and Uniphyl" @default.
• W2162912386 cites W1576341432 @default.
• W2162912386 cites W1650958547 @default.
• W2162912386 cites W1934840884 @default.
• W2162912386 cites W1969550355 @default.
• W2162912386 cites W2007998500 @default.
• W2162912386 cites W2008004084 @default.
• W2162912386 cites W2014361105 @default.
• W2162912386 cites W2019902007 @default.
• W2162912386 cites W2036707317 @default.
• W2162912386 cites W2040295649 @default.
• W2162912386 cites W2104310010 @default.
• W2162912386 cites W2158159024 @default.
• W2162912386 cites W2164828180 @default.
• W2162912386 doi "https://doi.org/10.1002/j.1552-4604.1987.tb05579.x" @default.
• W2162912386 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3429692" @default.
• W2162912386 hasPublicationYear "1987" @default.
• W2162912386 type Work @default.
• W2162912386 sameAs 2162912386 @default.
• W2162912386 citedByCount "3" @default.
• W2162912386 countsByYear W21629123862013 @default.
• W2162912386 crossrefType "journal-article" @default.
• W2162912386 hasAuthorship W2162912386A5023234261 @default.
• W2162912386 hasAuthorship W2162912386A5048130211 @default.
• W2162912386 hasAuthorship W2162912386A5066954652 @default.
• W2162912386 hasConcept C112705442 @default.
• W2162912386 hasConcept C121332964 @default.
• W2162912386 hasConcept C125287762 @default.
• W2162912386 hasConcept C126322002 @default.
• W2162912386 hasConcept C140793950 @default.
• W2162912386 hasConcept C147789679 @default.
• W2162912386 hasConcept C181389837 @default.
• W2162912386 hasConcept C185592680 @default.
• W2162912386 hasConcept C22979827 @default.
• W2162912386 hasConcept C24890656 @default.
• W2162912386 hasConcept C2776042228 @default.
• W2162912386 hasConcept C2776202631 @default.
• W2162912386 hasConcept C2777288759 @default.
• W2162912386 hasConcept C2778095195 @default.
• W2162912386 hasConcept C2778335254 @default.
• W2162912386 hasConcept C2781018748 @default.
• W2162912386 hasConcept C55493867 @default.
• W2162912386 hasConcept C71924100 @default.
• W2162912386 hasConcept C8171440 @default.
• W2162912386 hasConcept C86803240 @default.
• W2162912386 hasConcept C98274493 @default.
• W2162912386 hasConceptScore W2162912386C112705442 @default.
• W2162912386 hasConceptScore W2162912386C121332964 @default.
• W2162912386 hasConceptScore W2162912386C125287762 @default.
• W2162912386 hasConceptScore W2162912386C126322002 @default.
• W2162912386 hasConceptScore W2162912386C140793950 @default.
• W2162912386 hasConceptScore W2162912386C147789679 @default.
• W2162912386 hasConceptScore W2162912386C181389837 @default.
• W2162912386 hasConceptScore W2162912386C185592680 @default.
• W2162912386 hasConceptScore W2162912386C22979827 @default.
• W2162912386 hasConceptScore W2162912386C24890656 @default.
• W2162912386 hasConceptScore W2162912386C2776042228 @default.
• W2162912386 hasConceptScore W2162912386C2776202631 @default.
• W2162912386 hasConceptScore W2162912386C2777288759 @default.
• W2162912386 hasConceptScore W2162912386C2778095195 @default.
• W2162912386 hasConceptScore W2162912386C2778335254 @default.
• W2162912386 hasConceptScore W2162912386C2781018748 @default.
• W2162912386 hasConceptScore W2162912386C55493867 @default.
• W2162912386 hasConceptScore W2162912386C71924100 @default.
• W2162912386 hasConceptScore W2162912386C8171440 @default.
• W2162912386 hasConceptScore W2162912386C86803240 @default.
• W2162912386 hasConceptScore W2162912386C98274493 @default.
• W2162912386 hasIssue "11" @default.
• W2162912386 hasLocation W21629123861 @default.
• W2162912386 hasLocation W21629123862 @default.
• W2162912386 hasOpenAccess W2162912386 @default.
• W2162912386 hasPrimaryLocation W21629123861 @default.
• W2162912386 hasRelatedWork W111595033 @default.
• W2162912386 hasRelatedWork W2018025807 @default.
• W2162912386 hasRelatedWork W2084824126 @default.
• W2162912386 hasRelatedWork W2097337757 @default.
• W2162912386 hasRelatedWork W2112624400 @default.
• W2162912386 hasRelatedWork W2124791986 @default.
• W2162912386 hasRelatedWork W2362455219 @default.
• W2162912386 hasRelatedWork W2383546778 @default.
• W2162912386 hasRelatedWork W2390358224 @default.
• W2162912386 hasRelatedWork W2410226956 @default.
• W2162912386 hasVolume "27" @default.
• W2162912386 isParatext "false" @default.
• W2162912386 isRetracted "false" @default.
• W2162912386 magId "2162912386" @default.
• W2162912386 workType "article" @default.